-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Ethyl 7-[6-(benzoylmethylamino)-5-methyl-3-pyridinyl]-1-cyclopropyl-1,4-dihydro-8-methyl-4-oxo-3-quinolinecarboxylate, also known as CX804, is a novel and potent inhibitor of the enzyme acid-sensing ion channel 3 (ASIC3).
This unique compound has been shown to have a wide range of applications in the chemical industry, particularly in the fields of pharmaceuticals, agrichemicals, and material science.
One of the most promising applications of CX804 is in the development of new drugs for the treatment of various diseases.
Its ability to inhibit ASIC3 makes it a potential treatment for conditions such as chronic pain, inflammation, and gastrointestinal disorders.
In addition, CX804 has been shown to have anti-cancer properties and may be useful in the treatment of cancer.
In the agrichemical industry, CX804 has applications as a plant growth regulator.
It has been shown to promote plant growth and increase yields by modulating the activity of ASIC3 in plants.
This makes it a potentially useful tool for increasing crop yields and improving the health and vigor of plants.
In material science, CX804 has potential uses as a functional material.
Its unique chemical structure and properties make it a promising candidate for use in a variety of applications, such as in the development of new materials for energy storage and conversion, or as a component in nanotechnology.
In addition to these specific applications, CX804 has a wide range of potential applications in the chemical industry due to its unique structure and properties.
As research continues to uncover new applications for this compound, it is likely that it will play an increasingly important role in the chemical industry in the years to come.
It is worth noting that CX804 is still in the research stage and has not yet been tested or approved by the FDA for any medical use.
It is important to conduct further research and clinical trials to determine the safety and efficacy of the compound before it can be used in any medical or pharmaceutical applications.
In conclusion, Ethyl 7-[6-(benzoylmethylamino)-5-methyl-3-pyridinyl]-1-cyclopropyl-1,4-dihydro-8-methyl-4-oxo-3-quinolinecarboxylate (CX804) is a promising compound with a wide range of applications in the chemical industry, particularly in pharmaceuticals, agrichemicals, and material science.
Its unique properties and structure make it a potentially useful tool for treating a variety of diseases, promoting plant growth, and developing new materials.
As research continues, it is likely that CX804 will play an increasingly important role in the chemical industry in the years to come.